Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence
This study is currently recruiting participants.
Verified May 2013 by Creighton University
Sponsor:
Creighton University
Information provided by (Responsible Party):
Laura Armas, Creighton University
ClinicalTrials.gov Identifier:
NCT01605149
First received: May 22, 2012
Last updated: May 15, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Type 1 Diabetes Mellitus is a disease that has an effect on bone mineral density. It is unclear how and when it effects the bone density. The investigators are studying the effects of diabetes on bone mass compared to children without diabetes.
| Condition |
|---|
|
Type 1 Diabetes Mellitus |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Type 1 DM Bone Mineral Density in Childhood and Adolescence |
Resource links provided by NLM:
Further study details as provided by Creighton University:
| Estimated Enrollment: | 100 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Case
Patients with Type 1 Diabetes Mellitus
|
Eligibility| Ages Eligible for Study: | 5 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Children and adolescents with Type 1 DM
Criteria
Inclusion Criteria:
- We will recruit children from age 5 to age 18 with a diagnosis of Type 1 DM. Children will have various lengths of time since diagnosis.
Exclusion Criteria:
- We will exclude children on anticonvulsants or steroids and children with other concomitant illnesses that interfere with bone mass accrual, except for hypothyroidism on treatment.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01605149
Contacts
| Contact: Laura AG Armas, MD | 402-280-4470 | larmas@creighton.edu |
| Contact: Bethanie West | 402-280-4470 | bethaniewest@creighton.edu |
Locations
| United States, Nebraska | |
| Creighton University | Recruiting |
| Omaha, Nebraska, United States, 68131 | |
| Contact: Margaret Begley, RN, BSN 402-280-4470 mamb@creighton.edu | |
| Principal Investigator: Laura AG Armas, MD | |
Sponsors and Collaborators
Creighton University
Investigators
| Principal Investigator: | Laura AG Armas, MD | Creighton University |
More Information
No publications provided
| Responsible Party: | Laura Armas, Assistant Professor, Creighton University |
| ClinicalTrials.gov Identifier: | NCT01605149 History of Changes |
| Other Study ID Numbers: | 12-16425 |
| Study First Received: | May 22, 2012 |
| Last Updated: | May 15, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Creighton University:
|
Diabetes |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013